Syndax Pharmaceuticals (SNDX) Shares Outstanding (Weighted Average) (2016 - 2025)
Historic Shares Outstanding (Weighted Average) for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to $46.1 million.
- Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) rose 4555.67% to $46.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $46.1 million, marking a year-over-year increase of 4555.67%. This contributed to the annual value of $46.1 million for FY2020, which is 4555.67% up from last year.
- As of Q4 2020, Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $46.1 million, which was up 4555.67% from $44.2 million recorded in Q3 2020.
- In the past 5 years, Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) registered a high of $46.1 million during Q4 2020, and its lowest value of $4.5 million during Q1 2016.
- Its 5-year average for Shares Outstanding (Weighted Average) is $26.1 million, with a median of $25.0 million in 2018.
- In the last 5 years, Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) soared by 2962087.04% in 2016 and then surged by 972.49% in 2017.
- Syndax Pharmaceuticals' Shares Outstanding (Weighted Average) (Quarter) stood at $14.6 million in 2016, then soared by 43.62% to $21.0 million in 2017, then increased by 20.83% to $25.4 million in 2018, then rose by 24.71% to $31.6 million in 2019, then soared by 45.56% to $46.1 million in 2020.
- Its Shares Outstanding (Weighted Average) was $46.1 million in Q4 2020, compared to $44.2 million in Q3 2020 and $40.6 million in Q2 2020.